Stephen Cornelissen/LinkedIn
Feb 4, 2026, 08:05
Stephen Cornelissen Honors the Life-Saving Impact of Blood Donation on World Cancer Day
Stephen Cornelissen, CEO of Australian Red Cross Lifeblood, shared on LinkedIn:
”On World Cancer Day, I’m reminded that behind every diagnosis is a person and a story shaped by resilience, fear, hope, and the people who stand beside them.
Blood cancer patients are the largest users of donated blood in Australia.
More than a third of all whole blood donations support cancer treatment, helping patients stay strong enough to undergo chemotherapy and other intensive therapies.
These donations don’t treat the cancer itself, but they make treatment possible.
It highlights the vital role Australian Red Cross Lifeblood donors play in supporting patients through treatment.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?